Cochrane Abstracts
Semaglutide for adults living with obesity
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Semaglutide for Adults Living With Obesity." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438273/all/Glucagon‐like_peptide‐1_analogues_for_overweight_or_obese_adults.
Semaglutide for adults living with obesity. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438273/all/Glucagon‐like_peptide‐1_analogues_for_overweight_or_obese_adults. Accessed November 7, 2025.
Semaglutide for adults living with obesity. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438273/all/Glucagon‐like_peptide‐1_analogues_for_overweight_or_obese_adults
Semaglutide for Adults Living With Obesity [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 November 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438273/all/Glucagon‐like_peptide‐1_analogues_for_overweight_or_obese_adults.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Semaglutide for adults living with obesity
ID - 438273
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438273/all/Glucagon‐like_peptide‐1_analogues_for_overweight_or_obese_adults
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
